News | June 03, 2007

Common Hospital Device Could Lead To Patient Infections

June 4, 2007 —Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country.

According to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, the device is a needle-less intravascular catheter connector valve, commonly used for hospital patients with a vascular catheter in place.

Vascular catheters are widely used in many types of patients for the infusion of medications, blood products or fluids, and the connector valve is the small piece of equipment that connects the catheter to the IV tubing.

The first generation of needle-less devices was introduced into medical care over a decade ago in order to prevent needlestick injuries and bloodborne pathogen exposure in health care workers. More recently, mechanical valves have been incorporated into the devices in an attempt to minimize the risk of catheter occlusion. Unfortunately, some of these devices may be putting patients in harm's way according to Mark Rupp, M.D.

"It really points out that even seemingly small changes in vascular access devices can have devastating unintended consequences, and how careful we need to be when people's lives are at stake," he said.

Rupp is an infectious diseases specialist at UNMC and The Nebraska Medical Center, and the principal investigator on the study. His team's findings were reported in the June 1 issue of Clinical Infectious Diseases, a leading scientific journal.

The particular needle-less connector valve in the study was introduced into clinical use in February 2005 at The Nebraska Medical Center, but later completely removed from clinical use when evidence associated the valve with an increased rate of bloodstream infection. Bloodstream infections are quite serious and can result in mortality or prolonged hospital stay.

The UNMC research team is one of the first groups in the country to note this trend. They initially presented their findings to the scientific medical community in the spring of 2006.

In performing blood cultures on patients hospitalized during the study period, the researchers determined that ICU patients with the needle-less connector valve experienced bloodstream infections at nearly three times the rate compared to the time period before the valve was used. In regular inpatient nursing units, the bloodstream infection rate more than doubled when the needle-less connector valves were in use.

With the needle-less connector valves, bloodstream infections in ICU patients increased from 3.87 infections per 1,000 catheter days to 10.64 infections per 1,000. In inpatient nursing units, the introduction of the connector valves resulted in an increase of bloodstream infections from 3.47 infections per 1,000 catheter days to 7.3 infections per 1,000. Since discontinuing the use of needle-less connector valves, Dr. Rupp noted that the bloodstream infection rate at The Nebraska Medical Center has returned to the accepted national benchmark level.

"Every hospital in the country is using similar types of devices," Dr Rupp said. "We felt it incumbent upon ourselves to report our study results in a scientific journal. In addition, we notified the Food and Drug Administration (FDA) and the manufacturer."

Dr. Rupp said similar needle-less connector valves are produced by at least six different manufacturers. "Many of these devices are being introduced into the health care arena without undergoing rigorous testing in clinical settings," he said. "Hospitals and doctors need to be aware of the increased risks potentially involved with using some of these devices."

Dr. Rupp said the valves have a shallow depression and rim. "It's possible that microbes and debris could collect in this depression, making them relatively resistant to cleansing or disinfectants," he said. "They also are opaque, making it more difficult for health care workers to observe if blood or infusion products are collecting within the valve."

Once the higher rate of bloodstream infections was determined, Dr. Rupp said the hospital immediately stopped using the mechanical needle-less connector valves and

For more information visit: www.unmc.edu

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Philips Launches IntraSight Interventional Applications Platform
Technology | Interventional Radiology | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
360 degree view inside an Interventional radiology lab at Henry Ford Hospital used for neuro-interventions and stroke.
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree photo view inside the neuro-interventional radiology lab at ...
Multisociety Position Statement Endorses Prostatic Artery Embolization
News | Interventional Radiology | May 02, 2019
A new position statement from interventional radiology professional societies in the U.S. and Europe states that...
Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...